Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other...
from NDTV News - Topstories https://ift.tt/3d5VAV8
https://ift.tt/eA8V8J
Sunday, April 11, 2021
Home »
» China's Sinovac Cuts Risk Of Symptomatic Covid But 50% Effective: Study
0 comments:
Post a Comment